Tighter Controls For Pseudoephedrine OTCs In France
Executive Summary
Popular OTC drugs from J&J, Sanofi and Reckitt Benckiser are among those affected by new rules for the dispensing of pseudoephedrine-containing products in France following a spike in adverse events related to misuse of oral vasoconstrictors.
You may also be interested in...
France Advises Against Pseudoephedrine Use With EMA Safety Review Ongoing
As EMA's ongoing safety review of OTC decongestant pseudoephedrine enters its tenth month, France has decided to take action before any recommendations are issued. National medicines regulator ANSM is advising consumers not to use pseudoephedrine to treat their cold symptoms, much to the dismay of the local consumer health industry.
Pseudoephedrine Safety Review Initiated In EU Over Link To Neurological Problems
Reports of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome have triggered a European Union-wide safety review of pseudoephedrine.
Sanofi Looks To Future After Difficult 2019
With Consumer Healthcare sales down for Sanofi in 2019, CEO Hudson says the firm must do more to turn performance around. Key to achieving this will be the creation of a more agile standalone OTC business.